亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

A Novel Method and Apparatus to Access the Left Heart for Cardiac Interventions

技術優勢
No longer requires trans-apical surgery or crossing the aortic or mitral valves via arterial approach or trans-atrial septal approachMinimizes injury to ventricular septum or coronary arteries
技術應用
Left ventricular access in the field of cardiac electrophysiology and cardiac surgery
詳細技術說明
Researchers at UCLA have developed a novel device that allows access of therapeutic and diagnostic devices into the left ventricle from the venous side. This device will create a platform for accessing left sided structures including the aortic and mitral valves.
*Abstract
UCLA researchers in the Division of Cardiology at the Geffen School of Medicine have developed novel devices and methods for allowing entirely intravascular access to the left ventricle, thereby precluding access via the apex of the heart percutaneously or by surgery.
*IP Issue Date
Jul 2, 2015
*Principal Investigation

Name: Kalyanam Shivkumar

Department:

申請號碼
20150182255
其他

Background

Many cardiac and vascular interventions, such as transapical aortic valve replacement, mitral valve repair and replacement, and retrograde aortic root endograft procedures require safe and reliable direct percutaneous access and closure of access to the left ventricle. Direct left ventricular (LV) access involving trans-atrial or trans-septal surgery risks injury to critical structures, including the ventricular septum or coronary arteries, and requires immediate recognition of procedural complications, including pericardial tamponade or hemothorax.


Tech ID/UC Case

28731/2008-788-0


Related Cases

2008-788-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備